Publication | Open Access
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
1.3K
Citations
31
References
2012
Year
Breast OncologyOncologyPathologyBreast CancerCancer TreatmentMedicineRadiation OncologyPhase 3
| Year | Citations | |
|---|---|---|
Page 1
Page 1